Mandate

Vinge advises Isofol in connection with capital procurement

Vinge has advised Isofol Medical AB (publ), Nasdaq First North Premier Growth Market, in connection with a fully guaranteed rights issue and exercised over-allotment option which together add SEK 500 million to Isofol before transaction costs.

Vinge’s team primarily consisted of Anders StridEdin AgicJenny Sandlund and Beatrice Randow.

Related

Vinge has advised Eleda in connection with its acquisition of Rail Solutions Scandinavia AB, Gridtec AB, Quantity Surveying Konsult Stockholm AB, Voene AB, Vägservice centralen i Norden AB and Frästech AB.

Vinge has advised the leading infrastructure group Eleda in connection with its parallel acquisitions of Rail Solutions Scandinavia (railway maintenance), Gridtec (engineering consultancy in electric power), Quantity Surveying Konsult Stockholm (cost control and project management), Voene (traffic safety), Vägservice centralen i Norden and Frästech (road and bridge maintenance). The acquired businesses had a strong profitability with a combined turnover of approximately 200 MSEK in 2024.
June 04, 2025

Vinge has advised Marginalen Bank regarding a substitution of issuer for its existing capital notes and the issuance of new capital notes

Vinge has advised Marginalen Bank Bankaktiebolag (publ) regarding a change of issuer for its outstanding capital notes, consisting of SEK 560 million in Tier 2 Capital Notes and SEK 200 million Additional Tier 1 Capital Notes. ESCO Marginalen AB (publ) will assume all obligations under the existing capital notes in connection with the transaction, while Marginalen Bank issues new capital notes in a corresponding amount by way of set-off.
June 03, 2025